- Home
- TILE vs BCRX Comparison
TILE vs BCRX Comparison
Compare TILE & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TILE | BCRX |
|---|---|---|
| Founded | 1973 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.1B |
| IPO Year | 1994 | 1995 |
Fundamental Metrics
Financial Performance| Metric | TILE | BCRX |
|---|---|---|
| Price | $35.08 | $9.70 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 11 |
| Target Price | ★ $36.00 | $20.82 |
| AVG Volume (30 Days) | 586.4K | ★ 5.8M |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.29% | N/A |
| EPS Growth | 32.43 | ★ 381.40 |
| EPS | ★ 0.40 | N/A |
| Revenue | ★ $1,386,854,000.00 | $25,186,000.00 |
| Revenue This Year | $6.72 | N/A |
| Revenue Next Year | $5.61 | $12.55 |
| P/E Ratio | $89.18 | ★ N/A |
| Revenue Growth | ★ 5.41 | N/A |
| 52 Week Low | $20.37 | $6.00 |
| 52 Week High | $36.66 | $10.94 |
Technical Indicators
Market Signals| Indicator | TILE | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 72.28 | 59.72 |
| Support Level | $27.01 | $8.13 |
| Resistance Level | N/A | $10.32 |
| Average True Range (ATR) | 1.03 | 0.51 |
| MACD | 0.29 | 0.08 |
| Stochastic Oscillator | 83.08 | 55.82 |
Price Performance
Historical ComparisonAbout TILE Interface Inc.
Interface Inc is engaged in the design, production, and sale of carpet tiles. It also provides Luxury Vinyl tiles and rubber flooring. The company mainly targets corporate and noncorporate office markets, including government, education, healthcare, hospitality, and retailers. Its geographical segments include the Americas, Europe, and Asia-Pacific. It has two operating and reportable segments- namely Americas (AMS) and Europe, Africa, Asia and Australia (collectively EAAA). Key revenue is generated from AMS segment. Its products include: ESD, Acoustic, Extreme Wear, and Quick Installation System (nTx).
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.